Provided by Tiger Trade Technology Pte. Ltd.

Kinetik Holdings Inc.

54.12
-0.9100-1.65%
Post-market: 54.120.00000.00%19:30 EDT
Volume:613.57K
Turnover:33.34M
Market Cap:8.87B
PE:19.76
High:55.00
Open:54.64
Low:54.10
Close:55.03
52wk High:56.10
52wk Low:31.33
Shares:163.84M
Float Shares:62.93M
Volume Ratio:0.68
T/O Rate:0.97%
Dividend:3.21
Dividend Rate:5.93%
EPS(TTM):2.74
EPS(LYR):2.63
ROE:19.23%
ROA:1.96%
PB:-7.48
PE(LYR):20.58

Loading ...

RBC Raises Price Target on Kinetik Holdings to $50 From $49, Keeps Outperform Rating

MT Newswires Live
·
Apr 16

Kinetik Holdings Is Maintained at Hold by Jefferies

Dow Jones
·
Apr 16

Analysts Offer Insights on Energy Companies: Kinetik (KNTK) and Borr Drilling (BORR)

TIPRANKS
·
Apr 16

Kinetik Holdings price target raised to $50 from $49 at Jefferies

TIPRANKS
·
Apr 16

Press Release: Kinetik Announces Quarterly Dividend and Financial Results Timing

Dow Jones
·
Apr 15

Kinetik Keeps Quarterly Dividend at $0.81 per Share, Payable May 1 to Holders of Record April 24

MT Newswires Live
·
Apr 15

Kinetik publishes update to financial calendar

Reuters
·
Apr 15

Kinetik Holdings Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Apr 10

Kinetik Holdings announces annual shareholder meeting via webcast

Reuters
·
Apr 09

Kinetik extends A/R securitization facility to March 2027, cuts limit to $225 million

Reuters
·
Apr 04

Kinetik Holdings upgraded to Overweight from Equal Weight at Wells Fargo

TIPRANKS
·
Mar 25

Kinetik Holdings Initiated at Buy by Truist Securities

Dow Jones
·
Mar 24

Kinetik Holdings initiated with a Buy at Truist

TIPRANKS
·
Mar 24

Kinetik Holdings Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Mar 19

Kinetik Holdings price target raised to $44 from $43 at Barclays

TIPRANKS
·
Mar 19

Kinetik (KNTK) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Mar 19

Kinetik Holdings price target raised to $51 from $49 at Scotiabank

TIPRANKS
·
Mar 17

Kinetik Holdings Inc : Scotiabank Raises Target Price to $51 From $49

THOMSON REUTERS
·
Mar 17

U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson

Reuters
·
Mar 17

Kinetik Holdings Is Maintained at Neutral by UBS

Dow Jones
·
Mar 17